Robert Schnoll

24PUBLICATIONS
60CO-AUTHORS
Reinforcement learningData and information privacyPredictive and prognostic markersNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 31, 2025
Training a Smoking Status Probabilistic Model Using Cotinine Levels in a Large Claims Database.

Dominique Medaglio, Charles E Leonard, Alisa J Stephens Shields

|Jun 27, 2025
Differences in Cognition and Smoking Abstinence Rates Among People With and Without HIV Who Smoke.

Sera Levy, Robert A Schnoll, E Paul Wileyto

|May 13, 2025
Daily Cigarette Abstinence and Smoking Rate With Varenicline: Relationships With Treatment, Craving, and Affect During the First Week of the Quit Attempt.

Sarah S Tonkin, Jennifer M Betts, Ashley N Dowd

|Dec 20, 2024
Predictive Value of Individual Behavioral Risk Factors for New Mood-Related Psychiatric Disorder After Diagnosis of Cancer.

Seiichi Villalona, Carlos Chavez Perez, E Paul Wileyto

|May 23, 2024
A Pilot Study to Evaluate the Use of Automated Nicotine Metabolite Ratio Reporting Within Primary Care as an Implementation Strategy to Increase the Use of Tobacco Treatments.

Robert Schnoll, Frank T Leone, Anna-Marika Bauer

|Nov 07, 2023
Seeing Through the Blind: Belief About Treatment Randomization and Smoking Cessation Outcome Among People With Current or Past Major Depressive Disorder Who Smoke in a Placebo-Controlled Trial of Varenicline.

Robert Schnoll, E Paul Wileyto, Anna-Marika Bauer

Pageof 4